Froimson Mark
SEC CIK 1709050 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | Dir | 26.5K | $16.2K | $70.3K | 9 | 2021-12-17 | 2026-06-10 |
Most active insiders at PCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cross Shawn | CFO | — | $1.52M |
| 2 | WILLIAMS KRISTEN | Chief Administrative Off | — | $498.2K |
| 3 | RIKER LAUREN | SVP, Fin | — | $261.3K |
| 4 | SLONIN JONATHAN | Chief Medical Off | — | $240.4K |
| 5 | Froimson Mark | Dir | — | $10.9K |
| 6 | BIGAL MARCELO | Dir | — | — |
| 7 | Young Alethia | Dir | — | — |
| 8 | Teehan Brendan | Chief Commercial Off | — | — |
| 9 | Lee Frank D. | CEO, Dir | — | — |
| 10 | CHRISTIE CHRISTOPHER | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 21:06 | 2026-06-10 | PCRX | Pacira BioSciences, Inc. | Froimson Mark | Dir | A - Grant | $0.00 | +6,405 | 26.5K | +32% | $0 |
| 2026-03-19 | 2026-03-17 | PCRX | Pacira BioSciences, Inc. | Froimson Mark | Dir | S - Sale | $21.81 | -500 | 20.1K | -2% | -$10.9K | |
| D | 2025-06-13 | 2025-06-11 | PCRX | Pacira BioSciences, Inc. | Froimson Mark | Dir | A - Grant | $0.00 | +6,163 | 20.6K | +43% | $0 |
| 2024-08-12 | 2024-08-12 | PCRX | Pacira BioSciences, Inc. | Froimson Mark | Dir | P - Purchase | $11.58 | +1,400 | 14.5K | +11% | +$16.2K | |
| D | 2024-06-13 | 2024-06-12 | PCRX | Pacira BioSciences, Inc. | Froimson Mark | Dir | A - Grant | $0.00 | +5,230 | 13.1K | +67% | $0 |
| D | 2023-06-16 | 2023-06-14 | PCRX | Pacira BioSciences, Inc. | Froimson Mark | Dir | A - Grant | $0.00 | +1,775 | 7,843 | +29% | $0 |
| D | 2022-06-08 | 2022-06-08 | PCRX | Pacira BioSciences, Inc. | Froimson Mark | Dir | A - Grant | $0.00 | +1,160 | 6,068 | +24% | $0 |
| 2022-05-11 | 2022-05-09 | PCRX | Pacira BioSciences, Inc. | Froimson Mark | Dir | S - Sale | $59.37 | -1,000 | 4,908 | -17% | -$59.4K | |
| 2021-12-20 | 2021-12-17 | PCRX | Pacira BioSciences, Inc. | Froimson Mark | Dir | G - Gift | $0.00 | -400 | 5,908 | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations